DY131

1 1

Selleck Chemicals

S5364-10MG

€144,00 EUR
€144,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
View full details

DY131 is an activator of ERRbeta and ERRgamma used in studies of Hormone Signaling. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to ligand-dependent transcriptional programs and endocrine regulation in endocrinology models.

By activating ERRbeta and ERRgamma, DY131 can be used to examine ligand-dependent transcriptional programs and endocrine regulation. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In endocrinology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving ERRbeta and ERRgamma
  • Pathway perturbation studies connected to Hormone Signaling
  • Gain-of-function pathway-activation studies
  • Reporter-gene, receptor-binding, and transcriptional assays

Overall, DY131 is appropriate when a defined chemical perturbant is needed to connect ERRbeta and ERRgamma with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in endocrinology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
ERRbeta • ERRgamma
Target Class:
Nuclear Receptor
Pathways:
Hormone Signaling
Research Area:
Endocrinology
CAS No.:
95167-41-2
Molecular Weight:
311.38
Formula:
C₁₈H₂₁N₃O₂
SMILES:
CCN(CC)C1=CC=C(C=C1)C=NNC(=O)C2=CC=C(C=C2)O
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.